A trailblazing technology developed at McMaster offers clinicians a way to perform objective brain health assessments — a game-changing advancement when it comes to diagnosing and developing treatment plans for patients with brain injuries.
Brain health technology developed at McMaster is closer than ever to changing how brain injury, dementia and cognitive impairment are evaluated.
COVID-19 is not just a respiratory disease. Its neurocognitive symptoms are not yet well defined, so reliable assessment is key to understanding how it affects the brain.
McMaster logo
McMaster logo
